3rd Quarter - Termination
SQUIRE PATTON BOGGS for BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC.
Firm
Income
$10,000
Expenses
—
Terminated
Sep 30, 2010
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Reimbursement and regulation of pharmaceutical and biological products in P.L. 111-148 ( The Patient Protection and Affordable Care Act ) and P.L. 111-152 ( The Health Care and Education Reconciliation Act ).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL | LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04 |
Health Issues HCR
S. 515, H.R. 1260, Patent Reform Act of 2009, S. 525/1252, H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009, S. 729, H.R. 1427, Promoting Innovation and Access to Live-Savings Medicine Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL | LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.